Objective: To calculate and compare the human capital approach (HCA) and fr
iction cost approach (FCA) methods for estimating the cost of lost producti
vity of migraineurs after the initiation of sumatriptan from a US societal
perspective.
Design: Secondary, retrospective analysis to a prospective observational st
udy.
Setting: A mixed-model managed care organisation in western Pennsylvania, U
SA.
Patients: Patients with migraine using sumatriptan therapy.
Interventions: Patient-reported questionnaires collected at baseline, 3 and
6 months after initiation of sumatriptan therapy.
Outcome measures: The cost of lost productivity estimated with the HCA and
FCA methods,
Results: Of the 178 patients who completed the study, 51% were full-time em
ployees, 13% were part-time, 18% were not working and 17% changed work stat
us. Twenty-four percent reported a clerical or administrative position. Fro
m the HCA. the estimated total cost of lost productivity for 6 months follo
wing the initiation of sumatriptan was $US 117 905 (1996 values). From the
FCA, the six-month estimated total cost of lost productivity ranged from $U
S28 329 to $US 117 905 (1996 values).
Conclusions: This was the first study to retrospectively estimate lost prod
uctivity of patients with migraine using the FCA methodology. Our results d
emonstrate that depending on the assumptions and illustrations employed, th
e FCA can yield lost productivity estimates that vary greatly as a percenta
ge of the HCA estimate. Prospective investigations are needed to better det
ermine the components and the nature of the lost productivity for chronic e
pisodic diseases such as migraine headache.